CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine - Quiz - MDSpire

CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine

  • By

  • Lucia Mazzotti

  • Gerardo Musuraca

  • Fabio Affaticati

  • Esther Bartholomeus

  • Diana Campillo-Davo

  • Carole Faghel

  • Chiara Zingaretti

  • Flavia Foca

  • Claudio Cerchione

  • Valentina Ancarani

  • Patricia Borges de Souza

  • Fabio Nicolini

  • Anna De Lucia

  • Anna Gaimari

  • Oriana Nanni

  • Vittorio Sambri

  • Giovanni Martinelli

  • Francesco Malaspina

  • Pieter Meysman

  • Eva Lion

  • Massimiliano Mazza

  • May 20, 2026

  • 0 min

Share

Original Source(s)

CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine

  • by Lucia Mazzotti, Gerardo Musuraca, Fabio Affaticati, Esther Bartholomeus, Diana Campillo-Davo, Carole Faghel, Chiara Zingaretti, Flavia Foca, Claudio Cerchione, Valentina Ancarani, Patricia Borges de Souza, Fabio Nicolini, Anna De Lucia, Anna Gaimari, Oriana Nanni, Vittorio Sambri, Giovanni Martinelli, Francesco Malaspina, Pieter Meysman, Eva Lion, Massimiliano Mazza

  • May 20, 2026

Related Content

Refining CAR-NK Design

Preclinical findings suggest that receptor design and timed kinase inhibition could help strengthen next-generation cell therapies.

  • March 4, 2026

  • 2 min
Bone Marrow Transplant: How Keck Medicine of USC Is Excelling in Survival Outcomes

Preet M. Chaudhary, MD, PhD, discusses the repeat ranking of the USC Norris Blood and Marrow Transplant and Cell Therapy Program as one of the nation’s elite allogeneic transplant programs with the highest survival outcomes.

  • by

  • February 13, 2026

  • 12 min
Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma